These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23628063)

  • 41. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
    Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
    Hatachi S; Kunitomi A; Aozasa K; Yagita M
    Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder].
    Tanioka R; Mori S; Nakanishi T; Fujita S; Nakamichi N; Tajima K; Uemura Y; Amakawa R; Kishimoto Y; Fukuhara S
    Rinsho Ketsueki; 2007 Nov; 48(11):1492-7. PubMed ID: 18080508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease.
    Hayashi K; Joko H; Koirala TR; Onoda S; Jin ZS; Munemasa M; Ohara N; Oda W; Tanaka T; Oka T; Kondo E; Yoshino T; Takahashi K; Yamada M; Akagi T
    Histol Histopathol; 2003 Oct; 18(4):1155-68. PubMed ID: 12973684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [EB virus-positive T/NK lymphoproliferative diseases: an analysis of 156 patients].
    Zhang YL; Xie JL; Zheng YY; Wei P; Huang YH; Zheng XD; Teng XJ; Liu W; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):407-411. PubMed ID: 29886582
    [No Abstract]   [Full Text] [Related]  

  • 46. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epstein-Barr virus associated T-cell lymphoproliferative disease misdiagnosed as ulcerative colitis: a case report.
    Zheng X; Xie J; Zhou X
    Int J Clin Exp Pathol; 2015; 8(7):8598-602. PubMed ID: 26339440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disorders of childhood with fulminant leukocytosis and tumor lysis: a case report with autopsy findings.
    Wada S; Suzuki T; Kitazume K; Fujita A; Shimizu S
    Int J Hematol; 2018 Jul; 108(1):112-117. PubMed ID: 29218495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous EBV-related lymphoproliferative disorders.
    Gru AA; Jaffe ES
    Semin Diagn Pathol; 2017 Jan; 34(1):60-75. PubMed ID: 27988064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [EBV-associated lymphoproliferative disorders].
    Overkamp M; Quintanilla-Martinez L; Fend F
    Pathologie (Heidelb); 2022 Jul; 43(4):282-291. PubMed ID: 35925225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virus-specific cytotoxic T lymphocytes as prophylaxis for Epstein-Barr virus lymphoproliferative disease in pediatric bone marrow transplant recipients.
    Norville R; Nance D; Cheshire S
    J Pediatr Oncol Nurs; 1997 Oct; 14(4):194-201. PubMed ID: 9322393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits.
    Hayashi K; Ohara N; Teramoto N; Onoda S; Chen HL; Oka T; Kondo E; Yoshino T; Takahashi K; Yates J; Akagi T
    Am J Pathol; 2001 Apr; 158(4):1533-42. PubMed ID: 11290571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China.
    Huang W; Lv N; Ying J; Qiu T; Feng X
    Int J Clin Exp Pathol; 2014; 7(8):4991-9. PubMed ID: 25197370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
    Parvaneh N; Filipovich AH; Borkhardt A
    Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
    Tajima S; Takanashi Y; Koda K; Fukayama M
    Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.
    O'Mahony D; Morris JC; Stetler-Stevenson M; Matthews H; Brown MR; Fleisher T; Pittaluga S; Raffeld M; Albert PS; Reitsma D; Kaucic K; Hammershaimb L; Waldmann TA; Janik JE
    Clin Cancer Res; 2009 Apr; 15(7):2514-22. PubMed ID: 19293260
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
    Quintanilla-Martinez L; Swerdlow SH; Tousseyn T; Barrionuevo C; Nakamura S; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):227-244. PubMed ID: 36216980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunological aspects of Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Hara T
    Crit Rev Oncol Hematol; 2002 Dec; 44(3):203-15. PubMed ID: 12467961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical features of NK/T-cell EBV-associated LPD manifested as gastrointestinal symptoms in patients with normal immunity: a case report and literature review.
    Wang SZ; Dai YH; Zhang J; Lu FG; Yan LM; Wu S
    BMC Gastroenterol; 2021 Jun; 21(1):254. PubMed ID: 34112087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.